{"id":85105,"date":"2026-07-10T15:58:56","date_gmt":"2026-07-10T15:58:56","guid":{"rendered":"https:\/\/www.cofb.org\/?p=85105"},"modified":"2026-07-13T16:02:09","modified_gmt":"2026-07-13T16:02:09","slug":"el-programa-de-formacio-continuada-2025-2026-tanca-el-curs-amb-el-forum-dermoexpert-epigenetica-noves-bases-per-a-la-dermocosmetica","status":"publish","type":"post","link":"https:\/\/www.cofb.org\/es\/2026\/07\/10\/el-programa-de-formacio-continuada-2025-2026-tanca-el-curs-amb-el-forum-dermoexpert-epigenetica-noves-bases-per-a-la-dermocosmetica\/","title":{"rendered":"El Programa de Formaci\u00f3n Continua 2025-2026 cierra el curso con el Foro Dermoexpert \u201cEpigen\u00e9tica: nuevas bases para la dermocosm\u00e9tica\u201d"},"content":{"rendered":"<p>El pasado 18 de junio, el <strong>Col\u00b7legi de Farmac\u00e8utics de Barcelona (COFB) <\/strong>organiz\u00f3 el \u00faltimo <strong>Foro Dermoexpert \u201cEpigen\u00e9tica: nuevas bases para la dermocosm\u00e9tica\u201d<\/strong>, con el patrocinio de<strong><a href=\"https:\/\/hddermocosmetics.com\/es\/\">HD Cosmetic Efficiency<\/a><\/strong>. El Foro fue impartido por <strong>Regina Pall\u00e1s<\/strong>, farmac\u00e9utica y directora de I+D de Dermogalenic Experts; <strong>Jose Lu\u00eds Mullor<\/strong>, bi\u00f3logo, doctor en bioqu\u00edmica y biolog\u00eda molecular y director cient\u00edfico y CEO de Bionos Biotech; y <strong>Miquel Serra<\/strong>, farmac\u00e9utico comunitario. La vocal de Dermofarmacia y Productos Sanitarios del COFB, <strong>Marta Alcalde<\/strong>, coordin\u00f3 la sesi\u00f3n dirigida a farmac\u00e9uticos de farmacia comunitaria.<\/p>\n\n\n\n<figure class=\"wp-block-image size-large\"><a href=\"https:\/\/www.cofb.org\/wp-content\/uploads\/2026\/07\/COFB_EPIGENETICA_08072026_1-scaled.jpg\" target=\"_blank\" rel=\" noreferrer noopener\"><img fetchpriority=\"high\" decoding=\"async\" width=\"1024\" height=\"576\" src=\"https:\/\/www.cofb.org\/wp-content\/uploads\/2026\/07\/COFB_EPIGENETICA_08072026_1-1024x576.jpg\" alt=\"D'esquerra a dreta: Marta Alcalde, Regina Pall\u00e0s i Miquel Serra. \" class=\"wp-image-85110\" srcset=\"https:\/\/www.cofb.org\/wp-content\/uploads\/2026\/07\/COFB_EPIGENETICA_08072026_1-1024x576.jpg 1024w, https:\/\/www.cofb.org\/wp-content\/uploads\/2026\/07\/COFB_EPIGENETICA_08072026_1-300x169.jpg 300w, https:\/\/www.cofb.org\/wp-content\/uploads\/2026\/07\/COFB_EPIGENETICA_08072026_1-768x432.jpg 768w, https:\/\/www.cofb.org\/wp-content\/uploads\/2026\/07\/COFB_EPIGENETICA_08072026_1-1536x864.jpg 1536w, https:\/\/www.cofb.org\/wp-content\/uploads\/2026\/07\/COFB_EPIGENETICA_08072026_1-2048x1152.jpg 2048w, https:\/\/www.cofb.org\/wp-content\/uploads\/2026\/07\/COFB_EPIGENETICA_08072026_1-18x10.jpg 18w\" sizes=\"(max-width: 1024px) 100vw, 1024px\" \/><\/a><figcaption class=\"wp-element-caption\">De izquierda a derecha: Marta Alcalde, Regina Pall\u00e0s y Miquel Serra. <\/figcaption><\/figure>\n\n\n\n<p>Los <strong>objetivos <\/strong>del Foro Dermoexpert fueron conocer los <strong>fundamentos cient\u00edficos de la epigen\u00e9tica<\/strong>, entender los <strong>mecanismos de acci\u00f3n de las mol\u00e9culas con actividad epigen\u00e9tica en la dermis<\/strong>, saber cu\u00e1l es el <strong>proceso de investigaci\u00f3n y elaboraci\u00f3n de estudios de eficacia<\/strong> y revisar <strong>la aplicaci\u00f3n pr\u00e1ctica de estos nuevos activos cosm\u00e9ticos<\/strong>.<\/p>\n\n\n\n<p>La vocal de Dermofarmacia y Productos Sanitarios del COFB, <strong>Marta Alcalde<\/strong>, destac\u00f3 que con esta formaci\u00f3n <strong>se cierra el ciclo de formaciones del Programa de Formaci\u00f3n Continuada 2025-2026<\/strong>. La formaci\u00f3n puso el foco al conocer c\u00f3mo <strong>la epigen\u00e9tica puede servir como base para crear nuevos activos cosm\u00e9ticos<\/strong> que puedan actuar en temas de envejecimiento cut\u00e1neo y saber en qu\u00e9 se basa esta ciencia\u201d, indic\u00f3 Alcalde.<\/p>\n\n\n\n<p>A continuaci\u00f3n, intervino <strong>Regina Pall\u00e1s<\/strong> que profundiz\u00f3 en la epigen\u00e9tica, sus fundamentos y la evidencia cient\u00edfica. La farmac\u00e9utica describi\u00f3 <strong>la epigen\u00e9tica<\/strong> c\u00f3mo <strong>&quot;el estudio sobre c\u00f3mo los factores externos interact\u00faan con nuestros genes, modificando su expresi\u00f3n sin alterar la secuencia del ADN&quot;.<\/strong> Seg\u00fan detall\u00f3, lo hacen a trav\u00e9s de <strong>mecanismos moleculares que funcionan como interruptores a trav\u00e9s de los cuales los genes se activan o desactivan<\/strong>. Sin embargo, introdujo el concepto <strong>de exposoma<\/strong>, que \u201c<strong>engloba la totalidad de las exposiciones ambientales y personales a lo largo de la vida<\/strong>\u201d. As\u00ed pues, <strong>&quot;cada exposici\u00f3n puede dejar una huella epigen\u00e9tica que modifica la expresi\u00f3n g\u00e9nica&quot;<\/strong>, aunque <strong>&quot;la exposoma no cambia la secuencia de nuestro ADN, pero s\u00ed puede modificar c\u00f3mo se expresan nuestros genes&quot;.<\/strong> En este contexto, asegur\u00f3 que \u201c<strong>la ciencia cosm\u00e9tica encuentra en la epigen\u00e9tica un gran potencial para desarrollar nuevas formulaciones con activos que regulan epigen\u00e9ticamente la expresi\u00f3n de aquellos genes de inter\u00e9s<\/strong>&quot;. Para mostrarlo, Pall\u00e1s comparti\u00f3 el caso de dos personas gemelas, con el mismo ADN, que muestran patrones de envejecimiento diferentes porque &quot;la exposoma les ha dejado una huella epigen\u00e9ticamente diferente&quot;.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><strong>Senescencia celular y envejecimiento de la piel<\/strong><\/h2>\n\n\n\n<p>En relaci\u00f3n con el envejecimiento de la piel, la farmac\u00e9utica hizo referencia a la <strong>senescencia celular<\/strong>, \u201c<strong>un estado de detenci\u00f3n del ciclo celular irreversible, acompa\u00f1ado de cambios fenot\u00edpicos y secretorios (SASP)<\/strong>\u201d Algunos de los factores que pueden desencadenar que las c\u00e9lulas entren en un estado de senescencia son el da\u00f1o en el ADN, el estr\u00e9s oxidativo o el deterioro de la autofagia.<\/p>\n\n\n\n<figure class=\"wp-block-image size-large\"><a href=\"https:\/\/www.cofb.org\/wp-content\/uploads\/2026\/07\/COFB_EPIGENETICA_08072026_2-scaled.jpg\" target=\"_blank\" rel=\" noreferrer noopener\"><img decoding=\"async\" width=\"1024\" height=\"576\" src=\"https:\/\/www.cofb.org\/wp-content\/uploads\/2026\/07\/COFB_EPIGENETICA_08072026_2-1024x576.jpg\" alt=\"Regina Pall\u00e0s en un moment de la seva intervenci\u00f3. \" class=\"wp-image-85111\" srcset=\"https:\/\/www.cofb.org\/wp-content\/uploads\/2026\/07\/COFB_EPIGENETICA_08072026_2-1024x576.jpg 1024w, https:\/\/www.cofb.org\/wp-content\/uploads\/2026\/07\/COFB_EPIGENETICA_08072026_2-300x169.jpg 300w, https:\/\/www.cofb.org\/wp-content\/uploads\/2026\/07\/COFB_EPIGENETICA_08072026_2-768x432.jpg 768w, https:\/\/www.cofb.org\/wp-content\/uploads\/2026\/07\/COFB_EPIGENETICA_08072026_2-1536x864.jpg 1536w, https:\/\/www.cofb.org\/wp-content\/uploads\/2026\/07\/COFB_EPIGENETICA_08072026_2-2048x1152.jpg 2048w, https:\/\/www.cofb.org\/wp-content\/uploads\/2026\/07\/COFB_EPIGENETICA_08072026_2-18x10.jpg 18w\" sizes=\"(max-width: 1024px) 100vw, 1024px\" \/><\/a><figcaption class=\"wp-element-caption\">Regina Pall\u00e0s en un momento de su intervenci\u00f3n. <\/figcaption><\/figure>\n\n\n\n<p>Ahora bien, Regina Pall\u00e0s indic\u00f3 que la <strong>modulaci\u00f3n de la epigen\u00e9tica<\/strong> ofrece v\u00edas para atenuar las se\u00f1ales pro-senescentes y restaurar un comportamiento celular m\u00e1s juvenil, sin eliminar el mecanismo de seguridad antitumoral. As\u00ed pues, <strong>&quot;la ciencia cosm\u00e9tica encuentra en la epigen\u00e9tica una v\u00eda para desarrollar activos con mecanismos de acci\u00f3n precisos y medibles&quot;.<\/strong><\/p>\n\n\n\n<p>Para cerrar su exposici\u00f3n, hizo referencia al <strong>proyecto CDTI<\/strong> que se centra en el desarrollo de c\u00f3cteles de activos con mecanismos de acci\u00f3n sobre un microARN del envejecimiento cut\u00e1neo.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><strong>Bionos, innovaci\u00f3n aplicada<\/strong><\/h2>\n\n\n\n<p>Seguidamente, <strong>Jose Lu\u00eds Mullor<\/strong>, bi\u00f3logo y doctor en bioqu\u00edmica y biolog\u00eda molecular, expuso la actividad de <strong>Bionos Biotech<\/strong>, uno <strong>instituto de investigaci\u00f3n del Hospital Universitario y Polit\u00e9cnico La Fe de Valencia<\/strong>. Mullor destac\u00f3 el modelo de colaboraci\u00f3n de Bionos con Dermogalenic Experts, \u201cun modelo de trabajo que transforma la hip\u00f3tesis cient\u00edfica en activos cosm\u00e9ticos con evidencia real\u201d y que se basa en tres palancas: la formulaci\u00f3n estrat\u00e9gica de preguntas, la ejecuci\u00f3n rigurosa con metodolog\u00eda y la traducci\u00f3n en argumentario y <em>claim<\/em>. De esta forma, el resultado son <strong>productos con eficacia demostrada que el farmac\u00e9utico puede argumentar con fundamento cient\u00edfico real<\/strong>.<\/p>\n\n\n\n<figure class=\"wp-block-image size-full is-resized\"><a href=\"https:\/\/www.cofb.org\/wp-content\/uploads\/2026\/07\/COFB_EPIGENETICA_08072026_3.png\" target=\"_blank\" rel=\" noreferrer noopener\"><img decoding=\"async\" width=\"567\" height=\"316\" src=\"https:\/\/www.cofb.org\/wp-content\/uploads\/2026\/07\/COFB_EPIGENETICA_08072026_3.png\" alt=\"Jose Lu\u00eds Mullor durant la seva presentaci\u00f3. \" class=\"wp-image-85112\" style=\"width:1005px;height:auto\" srcset=\"https:\/\/www.cofb.org\/wp-content\/uploads\/2026\/07\/COFB_EPIGENETICA_08072026_3.png 567w, https:\/\/www.cofb.org\/wp-content\/uploads\/2026\/07\/COFB_EPIGENETICA_08072026_3-300x167.png 300w, https:\/\/www.cofb.org\/wp-content\/uploads\/2026\/07\/COFB_EPIGENETICA_08072026_3-18x10.png 18w\" sizes=\"(max-width: 567px) 100vw, 567px\" \/><\/a><figcaption class=\"wp-element-caption\">Jose Lu\u00eds Mullor durante su presentaci\u00f3n. <\/figcaption><\/figure>\n\n\n\n<p>El bi\u00f3logo coment\u00f3 que el camino para pasar de una hip\u00f3tesis cient\u00edfica a un producto dermocosm\u00e9tico defendible requiere un protocolo de validaci\u00f3n estructurado, basado en la hip\u00f3tesis y el dise\u00f1o, la validaci\u00f3n <em>in vitro<\/em>, la validaci\u00f3n <em>in vivo<\/em>, la formulaci\u00f3n y el <em>claim, <\/em>avalado con datos, es decir, con evidencia cient\u00edfica real. A lo largo de su exposici\u00f3n, Mullor desgran\u00f3 la <strong>metodolog\u00eda de estudio<\/strong> (el modelo experimental, el dise\u00f1o del estudio y la tecnolog\u00eda de an\u00e1lisis) y los <strong>resultados del estudio<\/strong> (reproductibilidad del efecto, regulaci\u00f3n epigen\u00e9tica e impacto biol\u00f3gico).<\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><strong>Del laboratorio al mostrador de la farmacia<\/strong><\/h2>\n\n\n\n<p>Por \u00faltimo, intervino el farmac\u00e9utico comunitario <strong>Miquel Serra <\/strong>para explicar el cambio de enfoque en la recomendaci\u00f3n de un producto. En ese o\u00eddo, dijo que <strong>&quot;el cambio no est\u00e1 s\u00f3lo en el producto, est\u00e1 en el punto de partida y en c\u00f3mo se interpreta al paciente desde la farmacia comunitaria&quot;<\/strong>. Serra indic\u00f3 que un farmac\u00e9utico debe identificar la necesidad real del paciente, traducir el mecanismo en un beneficio claro, adaptar la recomendaci\u00f3n al contexto real y priorizar lo necesario para obtener un resultado. A su vez, recomend\u00f3 <strong>traducir la innovaci\u00f3n al lenguaje del cliente <\/strong>porque <strong>&quot;el farmac\u00e9utico hace cada d\u00eda lo que ning\u00fan investigador puede hacer, que es tomar conceptos complejos y traducirlos de forma clara y \u00fatil para el paciente&quot;.<\/strong><\/p>\n\n\n\n<figure class=\"wp-block-image size-large\"><a href=\"https:\/\/www.cofb.org\/wp-content\/uploads\/2026\/07\/COFB_EPIGENETICA_08072026_4.jpeg\" target=\"_blank\" rel=\" noreferrer noopener\"><img loading=\"lazy\" decoding=\"async\" width=\"1024\" height=\"576\" src=\"https:\/\/www.cofb.org\/wp-content\/uploads\/2026\/07\/COFB_EPIGENETICA_08072026_4-1024x576.jpeg\" alt=\"Miquel Serra en un moment de la seva presentaci\u00f3. \" class=\"wp-image-85113\" srcset=\"https:\/\/www.cofb.org\/wp-content\/uploads\/2026\/07\/COFB_EPIGENETICA_08072026_4-1024x576.jpeg 1024w, https:\/\/www.cofb.org\/wp-content\/uploads\/2026\/07\/COFB_EPIGENETICA_08072026_4-300x169.jpeg 300w, https:\/\/www.cofb.org\/wp-content\/uploads\/2026\/07\/COFB_EPIGENETICA_08072026_4-768x432.jpeg 768w, https:\/\/www.cofb.org\/wp-content\/uploads\/2026\/07\/COFB_EPIGENETICA_08072026_4-1536x864.jpeg 1536w, https:\/\/www.cofb.org\/wp-content\/uploads\/2026\/07\/COFB_EPIGENETICA_08072026_4-18x10.jpeg 18w, https:\/\/www.cofb.org\/wp-content\/uploads\/2026\/07\/COFB_EPIGENETICA_08072026_4.jpeg 2048w\" sizes=\"(max-width: 1024px) 100vw, 1024px\" \/><\/a><figcaption class=\"wp-element-caption\">Miquel Serra en un momento de su exposici\u00f3n.<\/figcaption><\/figure>\n\n\n\n<p>Por otra parte, diferenci\u00f3 la interpretaci\u00f3n de la piel del paciente en tres niveles para identificar la necesidad real y decidir la recomendaci\u00f3n m\u00e1s adecuada. As\u00ed, hizo referencia a la demanda expl\u00edcita, la lectura profesional y el mecanismo subyacente. El farmac\u00e9utico destac\u00f3 <strong>el rol del farmac\u00e9utico comunitario como referente que aporta &quot;claridad, seguridad y resultados reales&quot;<\/strong>.<\/p>\n\n\n\n<p>Para cerrar la sesi\u00f3n, el farmac\u00e9utico comparti\u00f3 una \u00faltima reflexi\u00f3n en torno a la epigen\u00e9tica, que <strong>&quot;nos ha ense\u00f1ado que el destino gen\u00e9tico no es una sentencia porque el entorno y las intervenciones activas pueden modificar c\u00f3mo y cu\u00e1ndo envejecen nuestras c\u00e9lulas&quot;.<\/strong><\/p>\n\n\n\n<p class=\"has-text-align-right\"><strong>Con el patrocinio de:<\/strong><\/p>\n\n\n\n<figure class=\"wp-block-image alignright size-full is-resized\"><a href=\"https:\/\/hddermocosmetics.com\/es\/\" target=\"_blank\" rel=\" noreferrer noopener\"><img loading=\"lazy\" decoding=\"async\" width=\"700\" height=\"155\" src=\"https:\/\/www.cofb.org\/wp-content\/uploads\/2026\/07\/HD_COSMETIC_transparent_700MC.png\" alt=\"\" class=\"wp-image-85106\" style=\"width:321px;height:auto\" srcset=\"https:\/\/www.cofb.org\/wp-content\/uploads\/2026\/07\/HD_COSMETIC_transparent_700MC.png 700w, https:\/\/www.cofb.org\/wp-content\/uploads\/2026\/07\/HD_COSMETIC_transparent_700MC-300x66.png 300w, https:\/\/www.cofb.org\/wp-content\/uploads\/2026\/07\/HD_COSMETIC_transparent_700MC-18x4.png 18w\" sizes=\"(max-width: 700px) 100vw, 700px\" \/><\/a><\/figure>\n\n\n\n<p><\/p>","protected":false},"excerpt":{"rendered":"<p>El pasado 18 de junio, el Colegio de Farmac\u00e9uticos de Barcelona (COFB) organiz\u00f3 el \u00faltimo Foro Dermoexpert \u201cEpigen\u00e9tica: nuevas bases para la dermocosm\u00e9tica\u201d, con el patrocinio de HD Cosmetic Efficiency. El F\u00f3rum fue impartido por Regina Pall\u00e1s, farmac\u00e9utica y directora de I+D de Dermogalenic Experts; Jose Lu\u00eds Mullor, bi\u00f3logo, [\u2026]<\/p>","protected":false},"author":3,"featured_media":85109,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_uag_custom_page_level_css":"","site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"disabled","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"set","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"categories":[23,57],"tags":[5600,18,19,153,443,2837,81,707,2820,70,155,323,326,637,5599],"class_list":["post-85105","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-destacats","category-mon-collegial","tag-adn","tag-cofb","tag-collegi-de-farmaceutics-de-barcelona","tag-cosmetica","tag-dermocosmetica","tag-dermoexpert","tag-dermofarmacia","tag-envelliment","tag-epigenetica","tag-formacio","tag-forum-dermoexpert","tag-genetica","tag-gens","tag-programa-de-formacio-continuada","tag-programa-de-formacio-continuada-2025-2026"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v22.4 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>El Programa de Formaci\u00f3 Continuada 2025-2026 tanca el curs amb el F\u00f2rum Dermoexpert \u201cEpigen\u00e8tica: noves bases per a la dermocosm\u00e8tica\u201d - Col\u00b7legi de Farmac\u00e8utics de Barcelona<\/title>\n<meta name=\"description\" content=\"El passat 18 de juny, el COFB va organitzar el darrer F\u00f2rum Dermoexpert \u201cEpigen\u00e8tica: noves bases per a la dermocosm\u00e8tica\u201d\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.cofb.org\/es\/2026\/07\/10\/el-programa-de-formacio-continuada-2025-2026-tanca-el-curs-amb-el-forum-dermoexpert-epigenetica-noves-bases-per-a-la-dermocosmetica\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"El Programa de Formaci\u00f3 Continuada 2025-2026 tanca el curs amb el F\u00f2rum Dermoexpert \u201cEpigen\u00e8tica: noves bases per a la dermocosm\u00e8tica\u201d - Col\u00b7legi de Farmac\u00e8utics de Barcelona\" \/>\n<meta property=\"og:description\" content=\"El passat 18 de juny, el COFB va organitzar el darrer F\u00f2rum Dermoexpert \u201cEpigen\u00e8tica: noves bases per a la dermocosm\u00e8tica\u201d\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.cofb.org\/es\/2026\/07\/10\/el-programa-de-formacio-continuada-2025-2026-tanca-el-curs-amb-el-forum-dermoexpert-epigenetica-noves-bases-per-a-la-dermocosmetica\/\" \/>\n<meta property=\"og:site_name\" content=\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/farmaceuticsbcn\/\" \/>\n<meta property=\"article:published_time\" content=\"2026-07-10T15:58:56+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-07-13T16:02:09+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.cofb.org\/wp-content\/uploads\/2026\/07\/COFB_EPIGENETICA_08072026_0-scaled.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2560\" \/>\n\t<meta property=\"og:image:height\" content=\"1440\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Berta Mart\u00ednez\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@farmaceuticsbcn\" \/>\n<meta name=\"twitter:site\" content=\"@farmaceuticsbcn\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"Berta Mart\u00ednez\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"7 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.cofb.org\/2026\/07\/10\/el-programa-de-formacio-continuada-2025-2026-tanca-el-curs-amb-el-forum-dermoexpert-epigenetica-noves-bases-per-a-la-dermocosmetica\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.cofb.org\/2026\/07\/10\/el-programa-de-formacio-continuada-2025-2026-tanca-el-curs-amb-el-forum-dermoexpert-epigenetica-noves-bases-per-a-la-dermocosmetica\/\"},\"author\":{\"name\":\"Berta Mart\u00ednez\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/person\/f32de3b41b812c85ff923cb4cc849063\"},\"headline\":\"El Programa de Formaci\u00f3 Continuada 2025-2026 tanca el curs amb el F\u00f2rum Dermoexpert \u201cEpigen\u00e8tica: noves bases per a la dermocosm\u00e8tica\u201d\",\"datePublished\":\"2026-07-10T15:58:56+00:00\",\"dateModified\":\"2026-07-13T16:02:09+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.cofb.org\/2026\/07\/10\/el-programa-de-formacio-continuada-2025-2026-tanca-el-curs-amb-el-forum-dermoexpert-epigenetica-noves-bases-per-a-la-dermocosmetica\/\"},\"wordCount\":1191,\"publisher\":{\"@id\":\"https:\/\/www.cofb.org\/#organization\"},\"image\":{\"@id\":\"https:\/\/www.cofb.org\/2026\/07\/10\/el-programa-de-formacio-continuada-2025-2026-tanca-el-curs-amb-el-forum-dermoexpert-epigenetica-noves-bases-per-a-la-dermocosmetica\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2026\/07\/COFB_EPIGENETICA_08072026_0-scaled.jpg\",\"keywords\":[\"ADN\",\"COFB\",\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"cosm\u00e8tica\",\"dermocosm\u00e8tica\",\"DermoExpert\",\"Dermofarm\u00e0cia\",\"envelliment\",\"epigen\u00e8tica\",\"Formaci\u00f3\",\"f\u00f2rum dermoexpert\",\"gen\u00e8tica\",\"gens\",\"programa de formaci\u00f3 continuada\",\"Programa de Formaci\u00f3 Continuada 2025-2026\"],\"articleSection\":[\"Destacats\",\"M\u00f3n col\u00b7legial\"],\"inLanguage\":\"es\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.cofb.org\/2026\/07\/10\/el-programa-de-formacio-continuada-2025-2026-tanca-el-curs-amb-el-forum-dermoexpert-epigenetica-noves-bases-per-a-la-dermocosmetica\/\",\"url\":\"https:\/\/www.cofb.org\/2026\/07\/10\/el-programa-de-formacio-continuada-2025-2026-tanca-el-curs-amb-el-forum-dermoexpert-epigenetica-noves-bases-per-a-la-dermocosmetica\/\",\"name\":\"El Programa de Formaci\u00f3 Continuada 2025-2026 tanca el curs amb el F\u00f2rum Dermoexpert \u201cEpigen\u00e8tica: noves bases per a la dermocosm\u00e8tica\u201d - Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"isPartOf\":{\"@id\":\"https:\/\/www.cofb.org\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.cofb.org\/2026\/07\/10\/el-programa-de-formacio-continuada-2025-2026-tanca-el-curs-amb-el-forum-dermoexpert-epigenetica-noves-bases-per-a-la-dermocosmetica\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.cofb.org\/2026\/07\/10\/el-programa-de-formacio-continuada-2025-2026-tanca-el-curs-amb-el-forum-dermoexpert-epigenetica-noves-bases-per-a-la-dermocosmetica\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2026\/07\/COFB_EPIGENETICA_08072026_0-scaled.jpg\",\"datePublished\":\"2026-07-10T15:58:56+00:00\",\"dateModified\":\"2026-07-13T16:02:09+00:00\",\"description\":\"El passat 18 de juny, el COFB va organitzar el darrer F\u00f2rum Dermoexpert \u201cEpigen\u00e8tica: noves bases per a la dermocosm\u00e8tica\u201d\",\"breadcrumb\":{\"@id\":\"https:\/\/www.cofb.org\/2026\/07\/10\/el-programa-de-formacio-continuada-2025-2026-tanca-el-curs-amb-el-forum-dermoexpert-epigenetica-noves-bases-per-a-la-dermocosmetica\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.cofb.org\/2026\/07\/10\/el-programa-de-formacio-continuada-2025-2026-tanca-el-curs-amb-el-forum-dermoexpert-epigenetica-noves-bases-per-a-la-dermocosmetica\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/www.cofb.org\/2026\/07\/10\/el-programa-de-formacio-continuada-2025-2026-tanca-el-curs-amb-el-forum-dermoexpert-epigenetica-noves-bases-per-a-la-dermocosmetica\/#primaryimage\",\"url\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2026\/07\/COFB_EPIGENETICA_08072026_0-scaled.jpg\",\"contentUrl\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2026\/07\/COFB_EPIGENETICA_08072026_0-scaled.jpg\",\"width\":2560,\"height\":1440},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.cofb.org\/2026\/07\/10\/el-programa-de-formacio-continuada-2025-2026-tanca-el-curs-amb-el-forum-dermoexpert-epigenetica-noves-bases-per-a-la-dermocosmetica\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Inici\",\"item\":\"https:\/\/novaorg.cofb.net\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"El Programa de Formaci\u00f3 Continuada 2025-2026 tanca el curs amb el F\u00f2rum Dermoexpert \u201cEpigen\u00e8tica: noves bases per a la dermocosm\u00e8tica\u201d\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.cofb.org\/#website\",\"url\":\"https:\/\/www.cofb.org\/\",\"name\":\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/www.cofb.org\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.cofb.org\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.cofb.org\/#organization\",\"name\":\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"url\":\"https:\/\/www.cofb.org\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png\",\"contentUrl\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png\",\"width\":500,\"height\":105,\"caption\":\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\"},\"image\":{\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/farmaceuticsbcn\/\",\"https:\/\/twitter.com\/farmaceuticsbcn\",\"https:\/\/www.instagram.com\/farmaceuticsbcn\/\",\"https:\/\/www.linkedin.com\/company\/farmaceuticsbcn\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/person\/f32de3b41b812c85ff923cb4cc849063\",\"name\":\"Berta Mart\u00ednez\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/d4c584dab5da1ee9e3c3df161c0aabec7075cc8211cd46ffc79bfe177aa78b01?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/d4c584dab5da1ee9e3c3df161c0aabec7075cc8211cd46ffc79bfe177aa78b01?s=96&d=mm&r=g\",\"caption\":\"Berta Mart\u00ednez\"},\"url\":\"https:\/\/www.cofb.org\/es\/author\/bmartinez\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"El Programa de Formaci\u00f3 Continuada 2025-2026 tanca el curs amb el F\u00f2rum Dermoexpert \u201cEpigen\u00e8tica: noves bases per a la dermocosm\u00e8tica\u201d - Col\u00b7legi de Farmac\u00e8utics de Barcelona","description":"El passat 18 de juny, el COFB va organitzar el darrer F\u00f2rum Dermoexpert \u201cEpigen\u00e8tica: noves bases per a la dermocosm\u00e8tica\u201d","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.cofb.org\/es\/2026\/07\/10\/el-programa-de-formacio-continuada-2025-2026-tanca-el-curs-amb-el-forum-dermoexpert-epigenetica-noves-bases-per-a-la-dermocosmetica\/","og_locale":"es_ES","og_type":"article","og_title":"El Programa de Formaci\u00f3 Continuada 2025-2026 tanca el curs amb el F\u00f2rum Dermoexpert \u201cEpigen\u00e8tica: noves bases per a la dermocosm\u00e8tica\u201d - Col\u00b7legi de Farmac\u00e8utics de Barcelona","og_description":"El passat 18 de juny, el COFB va organitzar el darrer F\u00f2rum Dermoexpert \u201cEpigen\u00e8tica: noves bases per a la dermocosm\u00e8tica\u201d","og_url":"https:\/\/www.cofb.org\/es\/2026\/07\/10\/el-programa-de-formacio-continuada-2025-2026-tanca-el-curs-amb-el-forum-dermoexpert-epigenetica-noves-bases-per-a-la-dermocosmetica\/","og_site_name":"Col\u00b7legi de Farmac\u00e8utics de Barcelona","article_publisher":"https:\/\/www.facebook.com\/farmaceuticsbcn\/","article_published_time":"2026-07-10T15:58:56+00:00","article_modified_time":"2026-07-13T16:02:09+00:00","og_image":[{"width":2560,"height":1440,"url":"https:\/\/www.cofb.org\/wp-content\/uploads\/2026\/07\/COFB_EPIGENETICA_08072026_0-scaled.jpg","type":"image\/jpeg"}],"author":"Berta Mart\u00ednez","twitter_card":"summary_large_image","twitter_creator":"@farmaceuticsbcn","twitter_site":"@farmaceuticsbcn","twitter_misc":{"Escrito por":"Berta Mart\u00ednez","Tiempo de lectura":"7 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.cofb.org\/2026\/07\/10\/el-programa-de-formacio-continuada-2025-2026-tanca-el-curs-amb-el-forum-dermoexpert-epigenetica-noves-bases-per-a-la-dermocosmetica\/#article","isPartOf":{"@id":"https:\/\/www.cofb.org\/2026\/07\/10\/el-programa-de-formacio-continuada-2025-2026-tanca-el-curs-amb-el-forum-dermoexpert-epigenetica-noves-bases-per-a-la-dermocosmetica\/"},"author":{"name":"Berta Mart\u00ednez","@id":"https:\/\/www.cofb.org\/#\/schema\/person\/f32de3b41b812c85ff923cb4cc849063"},"headline":"El Programa de Formaci\u00f3 Continuada 2025-2026 tanca el curs amb el F\u00f2rum Dermoexpert \u201cEpigen\u00e8tica: noves bases per a la dermocosm\u00e8tica\u201d","datePublished":"2026-07-10T15:58:56+00:00","dateModified":"2026-07-13T16:02:09+00:00","mainEntityOfPage":{"@id":"https:\/\/www.cofb.org\/2026\/07\/10\/el-programa-de-formacio-continuada-2025-2026-tanca-el-curs-amb-el-forum-dermoexpert-epigenetica-noves-bases-per-a-la-dermocosmetica\/"},"wordCount":1191,"publisher":{"@id":"https:\/\/www.cofb.org\/#organization"},"image":{"@id":"https:\/\/www.cofb.org\/2026\/07\/10\/el-programa-de-formacio-continuada-2025-2026-tanca-el-curs-amb-el-forum-dermoexpert-epigenetica-noves-bases-per-a-la-dermocosmetica\/#primaryimage"},"thumbnailUrl":"https:\/\/www.cofb.org\/wp-content\/uploads\/2026\/07\/COFB_EPIGENETICA_08072026_0-scaled.jpg","keywords":["ADN","COFB","Col\u00b7legi de Farmac\u00e8utics de Barcelona","cosm\u00e8tica","dermocosm\u00e8tica","DermoExpert","Dermofarm\u00e0cia","envelliment","epigen\u00e8tica","Formaci\u00f3","f\u00f2rum dermoexpert","gen\u00e8tica","gens","programa de formaci\u00f3 continuada","Programa de Formaci\u00f3 Continuada 2025-2026"],"articleSection":["Destacats","M\u00f3n col\u00b7legial"],"inLanguage":"es"},{"@type":"WebPage","@id":"https:\/\/www.cofb.org\/2026\/07\/10\/el-programa-de-formacio-continuada-2025-2026-tanca-el-curs-amb-el-forum-dermoexpert-epigenetica-noves-bases-per-a-la-dermocosmetica\/","url":"https:\/\/www.cofb.org\/2026\/07\/10\/el-programa-de-formacio-continuada-2025-2026-tanca-el-curs-amb-el-forum-dermoexpert-epigenetica-noves-bases-per-a-la-dermocosmetica\/","name":"El Programa de Formaci\u00f3 Continuada 2025-2026 tanca el curs amb el F\u00f2rum Dermoexpert \u201cEpigen\u00e8tica: noves bases per a la dermocosm\u00e8tica\u201d - Col\u00b7legi de Farmac\u00e8utics de Barcelona","isPartOf":{"@id":"https:\/\/www.cofb.org\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.cofb.org\/2026\/07\/10\/el-programa-de-formacio-continuada-2025-2026-tanca-el-curs-amb-el-forum-dermoexpert-epigenetica-noves-bases-per-a-la-dermocosmetica\/#primaryimage"},"image":{"@id":"https:\/\/www.cofb.org\/2026\/07\/10\/el-programa-de-formacio-continuada-2025-2026-tanca-el-curs-amb-el-forum-dermoexpert-epigenetica-noves-bases-per-a-la-dermocosmetica\/#primaryimage"},"thumbnailUrl":"https:\/\/www.cofb.org\/wp-content\/uploads\/2026\/07\/COFB_EPIGENETICA_08072026_0-scaled.jpg","datePublished":"2026-07-10T15:58:56+00:00","dateModified":"2026-07-13T16:02:09+00:00","description":"El passat 18 de juny, el COFB va organitzar el darrer F\u00f2rum Dermoexpert \u201cEpigen\u00e8tica: noves bases per a la dermocosm\u00e8tica\u201d","breadcrumb":{"@id":"https:\/\/www.cofb.org\/2026\/07\/10\/el-programa-de-formacio-continuada-2025-2026-tanca-el-curs-amb-el-forum-dermoexpert-epigenetica-noves-bases-per-a-la-dermocosmetica\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.cofb.org\/2026\/07\/10\/el-programa-de-formacio-continuada-2025-2026-tanca-el-curs-amb-el-forum-dermoexpert-epigenetica-noves-bases-per-a-la-dermocosmetica\/"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.cofb.org\/2026\/07\/10\/el-programa-de-formacio-continuada-2025-2026-tanca-el-curs-amb-el-forum-dermoexpert-epigenetica-noves-bases-per-a-la-dermocosmetica\/#primaryimage","url":"https:\/\/www.cofb.org\/wp-content\/uploads\/2026\/07\/COFB_EPIGENETICA_08072026_0-scaled.jpg","contentUrl":"https:\/\/www.cofb.org\/wp-content\/uploads\/2026\/07\/COFB_EPIGENETICA_08072026_0-scaled.jpg","width":2560,"height":1440},{"@type":"BreadcrumbList","@id":"https:\/\/www.cofb.org\/2026\/07\/10\/el-programa-de-formacio-continuada-2025-2026-tanca-el-curs-amb-el-forum-dermoexpert-epigenetica-noves-bases-per-a-la-dermocosmetica\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Inici","item":"https:\/\/novaorg.cofb.net\/"},{"@type":"ListItem","position":2,"name":"El Programa de Formaci\u00f3 Continuada 2025-2026 tanca el curs amb el F\u00f2rum Dermoexpert \u201cEpigen\u00e8tica: noves bases per a la dermocosm\u00e8tica\u201d"}]},{"@type":"WebSite","@id":"https:\/\/www.cofb.org\/#website","url":"https:\/\/www.cofb.org\/","name":"Col\u00b7legi de Farmac\u00e8utics de Barcelona","description":"","publisher":{"@id":"https:\/\/www.cofb.org\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.cofb.org\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/www.cofb.org\/#organization","name":"Col\u00b7legi de Farmac\u00e8utics de Barcelona","url":"https:\/\/www.cofb.org\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/","url":"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png","contentUrl":"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png","width":500,"height":105,"caption":"Col\u00b7legi de Farmac\u00e8utics de Barcelona"},"image":{"@id":"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/farmaceuticsbcn\/","https:\/\/twitter.com\/farmaceuticsbcn","https:\/\/www.instagram.com\/farmaceuticsbcn\/","https:\/\/www.linkedin.com\/company\/farmaceuticsbcn\/"]},{"@type":"Person","@id":"https:\/\/www.cofb.org\/#\/schema\/person\/f32de3b41b812c85ff923cb4cc849063","name":"Berta Mart\u00ednez","image":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.cofb.org\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/d4c584dab5da1ee9e3c3df161c0aabec7075cc8211cd46ffc79bfe177aa78b01?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/d4c584dab5da1ee9e3c3df161c0aabec7075cc8211cd46ffc79bfe177aa78b01?s=96&d=mm&r=g","caption":"Berta Mart\u00ednez"},"url":"https:\/\/www.cofb.org\/es\/author\/bmartinez\/"}]}},"uagb_featured_image_src":{"full":["https:\/\/www.cofb.org\/wp-content\/uploads\/2026\/07\/COFB_EPIGENETICA_08072026_0-scaled.jpg",2560,1440,false],"thumbnail":["https:\/\/www.cofb.org\/wp-content\/uploads\/2026\/07\/COFB_EPIGENETICA_08072026_0-150x150.jpg",150,150,true],"medium":["https:\/\/www.cofb.org\/wp-content\/uploads\/2026\/07\/COFB_EPIGENETICA_08072026_0-300x169.jpg",300,169,true],"medium_large":["https:\/\/www.cofb.org\/wp-content\/uploads\/2026\/07\/COFB_EPIGENETICA_08072026_0-768x432.jpg",768,432,true],"large":["https:\/\/www.cofb.org\/wp-content\/uploads\/2026\/07\/COFB_EPIGENETICA_08072026_0-1024x576.jpg",1024,576,true],"1536x1536":["https:\/\/www.cofb.org\/wp-content\/uploads\/2026\/07\/COFB_EPIGENETICA_08072026_0-1536x864.jpg",1536,864,true],"2048x2048":["https:\/\/www.cofb.org\/wp-content\/uploads\/2026\/07\/COFB_EPIGENETICA_08072026_0-2048x1152.jpg",2048,1152,true],"trp-custom-language-flag":["https:\/\/www.cofb.org\/wp-content\/uploads\/2026\/07\/COFB_EPIGENETICA_08072026_0-18x10.jpg",18,10,true]},"uagb_author_info":{"display_name":"Berta Mart\u00ednez","author_link":"https:\/\/www.cofb.org\/es\/author\/bmartinez\/"},"uagb_comment_info":0,"uagb_excerpt":"El passat 18 de juny, el Col\u00b7legi de Farmac\u00e8utics de Barcelona (COFB) va organitzar el darrer F\u00f2rum Dermoexpert \u201cEpigen\u00e8tica: noves bases per a la dermocosm\u00e8tica\u201d, amb el patrocini d\u2019HD Cosmetic Efficiency. El F\u00f2rum va ser impartit per Regina Pall\u00e1s, farmac\u00e8utica i directora d\u2019I+D de Dermogalenic Experts; Jose Lu\u00eds Mullor, bi\u00f2leg, [&hellip;]","_links":{"self":[{"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/posts\/85105","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/comments?post=85105"}],"version-history":[{"count":11,"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/posts\/85105\/revisions"}],"predecessor-version":[{"id":85123,"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/posts\/85105\/revisions\/85123"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/media\/85109"}],"wp:attachment":[{"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/media?parent=85105"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/categories?post=85105"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/tags?post=85105"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}